Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × Urinary Bladder Neoplasms × Genitourinary × Clear all

Status

Completed 603 Recruiting 238 Unknown 217 Terminated 146 Active not recruiting 105 Not yet recruiting 51 Withdrawn 47 Enrolling by invitation 9 Suspended 2 Available 2 No longer available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 12 Carcinoma, Renal Cell 4 Rhabdoid Tumor 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Sarcoma, Synovial 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Retinoblastoma 1 Prostatic Neoplasms, Castration-Resistant 1 Pinealoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neuroectodermal Tumors, Primitive 1 Neuroblastoma 1 Mesothelioma, Malignant 1 Meningeal Neoplasms 1 Melanoma 1 Medulloblastoma 1 Lung Neoplasms 1 Kidney Neoplasms 1 Hepatoblastoma 1 Disease 1 Desmoplastic Small Round Cell Tumor 1 Colorectal Neoplasms 1 Chondrosarcoma 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

bemarituzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03801278 2021-12-13

FPA144

Five Prime Therapeutics, Inc.

No longer available

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡